Tag: Schizophrenia

BI Researchers Decode Speech to Help Detect Warning Signals for Schizophrenia or Alzheimer

boehringer
Can an app for speech recognition calculate a person’s individual risk of schizophrenia or Alzheimer’s Dementia? An international team of neuroscientists and IT specialists at Boehringer Ingelheim wan...

Novel Agent for Schizophrenia Treatment Received BTD

Sunovion Pharmaceuticals Inc. (Sunovion) and PsychoGenics Inc. (PsychoGenics), announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for SEP-363856, a...

Alkermes Announces Positive Topline Results From Innovative Study for the Treatment of Schizophrenia...

Alkermes plc announced positive topline results from ALPINE (Aripiprazole Lauroxil and Paliperidone palmitate: INitiation Effectiveness), a first-of-its-kind, six-month study evaluating the ef...

Concert Pharma Announced the Initiation of Early-Stage Schizophrenia Study

Concert Pharmaceuticals, Inc. CNCE announced that it has initiated a multiple-ascending dose ("MAD") phase I study on its pipeline candidate, CTP-692 (a novel deuterium-modified form of D-serine), as ...

Latuda’s Positive Results for Patients with Schizophrenia

Japan-based Sumitomo Dainippon Pharma has published positive results from the phase III JEWEL trial into its drug Latuda (lurasidone hydrochloride) for patients with schizophrenia. The JEWEL study ...

Fast Track for Neurological and Psychiatric Diseases Drug

The FDA has granted Fast Track Designation to BioXcel Therapeutics’ BXCL501 for the treatment of acute agitation resulting from neurological and psychiatric disorders like Alzheimer’s and schizophreni...

Novartis to Test Pear’s Digital Therapeutic Treatment for Schizophrenia

Over the past year, Pear has shown it can convince regulators of the safety and efficacy of digital therapeutics by winning approvals for its treatments for substance use disorder, and most recently, ...